No patients that are known to be pregnant or nursing
Not pregnant and not nursing
Subject is pregnant, nursing or intends to become pregnant during the course of the study.
Pregnant and nursing females.
Females who are pregnant or nursing
Patients who are pregnant or actively nursing an infant are not eligible
Pregnant or nursing
Pregnant/nursing
Pregnant or nursing.
Are pregnant and/or nursing
Pregnant or nursing females
Pregnant or nursing
Pregnant or nursing
Pregnant or nursing
Patients who are pregnant or nursing
Pregnant or nursing females.
Patients who are pregnant or nursing.
Pregnant or nursing
Patients must not be pregnant or nursing
Females who are pregnant or nursing
Subjects must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants.
Subjects must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants
May not be pregnant or nursing
Non-pregnant and non-nursing; pregnant and nursing patients may not be enrolled; women and men of reproductive potential must agree to use acceptable forms of contraception during the study
Pregnant or nursing
Patients who are pregnant or nursing
Pregnant or nursing
Subjects who are pregnant or nursing
Patients who are pregnant or nursing
Pregnant or nursing
Subjects must not be pregnant or nursing
Pregnant or nursing patients
Pregnant or nursing
Pregnant or nursing
PHASE I: Patients must not be pregnant or nursing as the potential of this regimen to harm nursing infants has not been evaluated
PHASE II: Patients must not be pregnant or nursing as the potential of this regimen to harm nursing infants has not been evaluated
Subjects must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants.
Patients who are pregnant or nursing
Patients who are pregnant or nursing
Pregnant or nursing patients
Subjects must not be pregnant or nursing
Pregnant or nursing
Patients who are pregnant or nursing
Subjects must not be pregnant or nursing
Not pregnant and not nursing
Subjects who are pregnant or nursing
Subjects must not be pregnant or nursing
Females who are pregnant, intend to become pregnant, or are nursing at the time of randomization.
Patients who are pregnant or nursing
Are pregnant and/or nursing
Not pregnant or nursing
Pregnant or nursing females.
Are not pregnant or nursing;
Patients must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants
Pregnant or nursing
Pregnant or nursing
Patients must not be pregnant or nursing
May not be pregnant or nursing
Patients must not be pregnant or nursing
Subjects known to be pregnant or nursing.
Pregnant or nursing
Pregnant or nursing females
Nursing woman
Pregnant or nursing.
Pregnant or nursing
Not pregnant or nursing
Pregnant or nursing
Pregnant or nursing
Patients who are pregnant or nursing
Patients of childbearing potential, not practicing adequate contraception, patients who are pregnant or patients who are nursing are not eligible for this trial; bevacizumab should not be administered to nursing women
Pregnant and nursing females.
Patients who are pregnant or nursing
Non-pregnant and non-nursing
Pregnant or nursing
Is pregnant or nursing
Pregnant or nursing
Currently pregnant, nursing, or wishing to become pregnant during the study
Patients must be non-pregnant and non-nursing
Females who are nursing must agree to discontinue nursing before the first dose of GS-5829
Pregnant or nursing; or
Patients who are pregnant or nursing
Nursing and pregnant females
Pregnant or nursing
Females who are nursing must agree to discontinue nursing before the first dose of study drug
Pregnant or nursing females.
Participants who are pregnant or nursing
Subjects must not be pregnant or nursing
Pregnant or nursing
Pregnant or nursing.
Patients who are pregnant or nursing
Pregnant or nursing females
Patients who are pregnant or nursing
Females who are nursing must agree to discontinue nursing before the first dose of MMB
Patients who are pregnant or nursing are not eligible
Pregnant or nursing
Pregnant or nursing within past 6 months, or plans to become pregnant in the next year
Are pregnant or nursing, or intending to become pregnant within the duration of the study
Pregnant or nursing
Pregnant or nursing
Patients pregnant or nursing
Pregnant or nursing within past 6 months
Patients who are pregnant or nursing
Pregnant or nursing females
Pregnant or nursing
Patients who are pregnant or nursing.
Not pregnant or nursing
Subject is nursing or intends to begin nursing during the course of the study
Pregnant or nursing
Nursing or pregnant.
Patients who are pregnant, nursing, or who wish to become pregnant during the study
Patients who are pregnant or nursing
Is, within 2 weeks prior to Day 1, nursing.
Females who are pregnant or nursing.
Pregnant or nursing
Is nursing or pregnant
Females who are pregnant or currently nursing.
Pregnant or nursing females
Currently pregnant or nursing.
Is nursing or pregnant
Pregnant or nursing females;
Pregnant or nursing females.
Females who are nursing.
Pregnant or nursing
Patients must not be pregnant or nursing
Patients must not be pregnant or nursing
Participant is nursing or intends to begin nursing during the course of the study
Females who are pregnant or nursing a child at Baseline (within 24 hours prior to surgical procedure).
Subject is pregnant or nursing an infant
Are pregnant or nursing
Pregnant or nursing
Pregnant or nursing females.
Pregnant or nursing women. Pregnant and nursing patients are excluded because the effects of CWP232291 on a fetus or nursing child are unknown.
Pregnant or nursing
Participants who are pregnant or nursing
Pregnant or nursing
Not pregnant or nursing
Patients who are pregnant or nursing
Patients who are pregnant or nursing are ineligible
Females who are nursing
Pregnant or nursing
Pregnant or nursing
Participant is pregnant or nursing
Subject is pregnant or nursing
No exclusion criteria for pregnant or nursing patients from participating in this study (of note, pregnant patients will not be treated with vaginal brachytherapy, a requirement for enrolling on this study)
Not pregnant or nursing
Pregnant or nursing patients will not be included in the study
Females of childbearing potential who are pregnant or nursing
Currently pregnant, nursing, or wishing to become pregnant during the study
Non-pregnant and non-nursing
Nursing or pregnant females
Subject is pregnant or nursing
Nursing or pregnant females
Pregnant or nursing
Pregnant or nursing
Females who are pregnant or nursing
Females who are pregnant or nursing
Pregnant or nursing participants
Pregnant or nursing
Pregnant or nursing
Females who are pregnant or nursing
Pregnant or nursing
Pregnant or nursing
Pregnant or nursing females
Patients who are pregnant or nursing
Pregnant or nursing
Pregnant or nursing females.
Pregnant or nursing females
Pregnant or nursing females
Females who are pregnant or nursing.
Females who are pregnant or nursing
Subjects must not be pregnant or nursing
Pregnant or nursing
Are pregnant or nursing
Females who are pregnant or nursing
Pregnant or nursing
Known pregnant or nursing patients
Subjects who are pregnant or nursing
Females who are pregnant or nursing
Pregnant or nursing
Pregnant or nursing
Pregnant or nursing
Pregnant or nursing
